A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Lauren Seeberger, Christopher A. Ross et al.|Neurology|2016Cited by 137
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical TrialMichael Brownstein, Stephanie Lowenhaupt, Neal G. Simon et al.|Journal of Clinical Medicine|2020Cited by 32
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington diseaseAndrew McGarry, Lauren Seeberger, Michael McDermott et al.|Unknown|2017Cited by 28